Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats

Go back to Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
(NASDAQ: DCOY) Delayed: 2.63 --0 (-0%)
Previous Close $2.63    52 Week High
Open $2.63    52 Week Low
Day High $2.63    P/E N/A 
Day Low $2.63    EPS
Volume 67